MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2
- PMID: 31601272
- PMCID: PMC6786283
- DOI: 10.1186/s13072-019-0298-1
MeCP2-E1 isoform is a dynamically expressed, weakly DNA-bound protein with different protein and DNA interactions compared to MeCP2-E2
Abstract
Background: MeCP2-a chromatin-binding protein associated with Rett syndrome-has two main isoforms, MeCP2-E1 and MeCP2-E2, differing in a few N-terminal amino acid residues. Previous studies have shown brain region-specific expression of these isoforms which, in addition to their different cellular localization and differential expression during brain development, suggest that they may also have non-overlapping molecular mechanisms. However, differential functions of MeCP2-E1 and E2 remain largely unexplored.
Results: Here, we show that the N-terminal domains (NTD) of MeCP2-E1 and E2 modulate the ability of the methyl-binding domain (MBD) to interact with DNA as well as influencing the turn-over rates, binding dynamics, response to neuronal depolarization, and circadian oscillations of the two isoforms. Our proteomics data indicate that both isoforms exhibit unique interacting protein partners. Moreover, genome-wide analysis using ChIP-seq provide evidence for a shared as well as a specific regulation of different sets of genes.
Conclusions: Our study supports the idea that Rett syndrome might arise from simultaneous impairment of cellular processes involving non-overlapping functions of MECP2 isoforms. For instance, MeCP2-E1 mutations might impact stimuli-dependent chromatin regulation, while MeCP2-E2 mutations could result in aberrant ribosomal expression. Overall, our findings provide insight into the functional complexity of MeCP2 by dissecting differential aspects of its two isoforms.
Keywords: Chromatin; Isoforms; MeCP2; Rett syndrome.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- Lewis JD, Meehan RR, Henzel WJ, Maurer-Fogy I, Jeppesen P, Klein F, et al. Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA. Cell. 1992;69(6):905–914. - PubMed
-
- Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23(2):185–188. - PubMed
-
- Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet. 2004;36(4):339–341. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- MOP-130417/CIHR/Canada
- MOP-102758/CIHR/Canada
- 204PRO/University of Victoria-Genome BC Proteomics Centre/International
- 214PRO/University of Victoria-Genome BC Proteomics Centre/International
- CRC 1080/Max Planck Society and DFG/International
- CRC 902/Max Planck Society and DFG/International
- 743216 to EMS/European Research Council under the European Union's Horizon 2020 research and innovation program/International
- 727264 (EPIPHARM)/European Research Council under the European Union's Horizon 2020 research and innovation program/International
- BFU2013-47064-P/Spanish Ministerio de Economia y Competitividad/International
- BFU2016-78232-P/Spanish Ministerio de Economia y Competitividad/International
- SAF2014-55000-R/Spanish Ministerio de Economia y Competitividad/International
- PI15/00663/Instituto de Salud Carlos III and co-funded by European Union/International
- TFRI #1039/Terry Fox Research Institute Program Project/International
- CCSRI #703489/Canadian Cancer Society Research Institute/International
- AGAUR [2014SGR633]/Health and Science Departments of the Catalan Government (Generalitat de Catalunya)/International
